Stagliano Nancy — SEC insider filings

SEC reporting owner CIK 1817449. 2 insider filings on record with FilingPulse; latest filed 2026-09-21.

Transaction summary — filings shown

Covers all 2 filings on record, filed 2021-04-01 to 2026-09-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Pandion Therapeutics, Inc. (PAND)Director1——3
Electra Therapeutics, Inc. (ETRA)Director1——2

Insider filings — Stagliano Nancy

FiledFormIssuerReported transactionsSource
2026-09-214Electra Therapeutics, Inc. (ETRA)Conversion (C): 255,635 · Conversion (C): 255,635 (derivative)EDGAR
2021-04-014Pandion Therapeutics, Inc. (PAND)Code (U): 1,000 @ $60 · Code (U): 73,067 @ $60 · Disposition to issuer (D): 17,671 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-03-31 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1817449 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs